Animal models of cerebral β-amyloid angiopathy

Brain Research Reviews

Volumn 25, Issue 1, 1997, Pages 70-84

  Walker, Lary C ^a  

^a PFIZER INC   (United States)

Author keywords

Amyloid; Alzheimer's disease; Cystatin C; Stroke; Transgenic mice; Vascular

Indexed keywords

AMYLOID BETA PROTEIN; CYSTATIN C;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; DISEASE PREDISPOSITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; SENILE PLAQUE; SQUIRREL MONKEY; STROKE; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; DISEASE MODELS, ANIMAL; DOGS; HUMANS; MACACA MULATTA; MICE; PRIMATES; RISK FACTORS; SAIMIRI;

EID: 0030779705     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00017-9     Document Type: Review

References (166)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
2. Afagh A., Cummings B.J., Cribbs D.H., Cotman C.W., Tenner A.J. Localization and cell association of C1q in Alzheimer's disease brain. Exp. Neurol. 138:1996;22-32.
3. Baker H.F., Ridley R.M., Duchen L.W., Crow T.J., Bruton C.J. Evidence for the experimental transmission of cerebral β-amyloidosis to primates. Int. J. Exp. Path. 74:1993;441-454.
4. Bickel U., Lee V.M.-Y., Trojanowski J.Q., Pardridge W.M. Site protected, cationized monoclonal antibody against beta amyloid as a potential diagnostic imaging technique for Alzheimer's disease. Soc. Neurosci. Abstr. 18:1992;764.
5. Bons N., Jallageas V., Mestre-Francés N., Silhol S., Petter A., Delacourte A. Microcebus murinus, a convenient laboratory animal model for the study of Alzheimer's disease. Alzheimer's Res. 1:1995;83-87.
6. Bons N., Mestre N., Petter A. Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus. Neurobiol. Aging. 13:1991;99-105.
7. Bons N., Mestre N., Ritchie K., Peters A., Podlisny M., Selkoe D. Identification of amyloid beta protein in the brain of the short-lived lemurian primate Microcebus murinus. Neurobiol. Aging. 15:1994;215-220.
8. Bornebroek M., Haan J., Maat-Schieman M.L.C., Van Duinen S.G., Roos R.A.C. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). I - a review of clinical, radiologic and genetic aspects Brain Path. 6:1996;111-114.
9. Braunmühl A.V. 'Kongophile Angiopathie' und 'senile plaques' bei greisen Hunden. Arch. Psychiat. Z. Neurol. 194:1956;396-414.
10. K.R. Brizzee, J.M. Ordy, H. Hofer, B. Kaack, Animal models for the study of senile brain disease and aging changes in the brain, in: R. Katzman, R.D. Terry and K.L. Bick (Eds.) Aging, vol. 7, Raven Press, New York, 1978, pp. 515-553.
11. Bruce M.E., Dickinson A.G., Fraser H. Cerebral amyloidosis in scrapie in the mouse: effect of agent strain and mouse genotype. Neuropath. Appl. Neurobiol. 2:1976;471-478.
12. Bruce M.E., Fraser H. Amyloid plaques in the brains of mice infected with scrapie: morphological variation and staining properties. Neuropath. Appl. Neurobiol. 1:1975;189-202.
13. Calenda A., Jallegeas V., Silhol S., Bellis M., Bons N. Identification of a unique apolipoprotein E allele in Microcebus murinus; apoe brain distribution and co-localization with β-amyloid and tau proteins. Neurobiol. Dis. 2:1995;169-176.
14. Castaño E.M., Frangione B. Biology of disease. Human amyloidosis, Alzheimer disease and related disorders. Lab. Invest. 58:1988;122-132.
15. Cohen A.S. Amyloidosis. N. Engl. J. Med. 277:1967;522-530.
16. Coria F., Larrondo-Lillo M., Frangione B. Degeneration of smooth muscle cells in beta-amyloid angiopathies. J. Neuropath. Exp. Neurol. 48:1989;368.
17. Cork L.C., Hester-Price A. Aging and amyloid: a phylogenetic perspective. J. Neuropath. Exp. Neurol. 52:1993;335.
18. Cork L.C., Powers R.E., Selkoe D.J., Davies P., Geyer J.J., Price D.L. Neurofibrillary tangles and senile plaques in aged bears. J. Neuropath. Exp. Neurol. 47:1988;629-641.
19. L.C. Cork and L.C. Walker, Age-related lesions, nervous system, In T.C. Jones, U. Mohr, and R.D. Hunt (Eds.), Non-human Primates II, Springer-Verlag, New York, 1993, pp. 173-183.
20. Cruz-Sanchez F.F., Marin C., Rossi M.L., Cardozo A., Ferrer I., Tolosa E. Ubiquitin in cerebral amyloid angiopathy. J. Neurolog. Sci. 112:1992;46-50.
21. Cummings B.J., Su J.H., Cotman C.W., White R., Russell M.J. β-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol. Aging. 14:1993;547-560.
22. Dahme E., Schröder B. Kongophile Angiopathie, cerebrovasculäre Mikroaneurysmen und cerebrale Blutungen beim alten Hund. Zbl. Vet. Med. A. 26:1979;601-613.
23. Davis J., Van Nostrand W.E. Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Cell Biol. 93:1996;2996-3000.
24. Eikelenboom P., Stam F.C. An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer's dementia. Virchows Arch. [Cell Path.]. 47:1984;17-25.
25. Ellis R.J., Olichney J.M., Thal L.J., Mirra S.S., Morris J.C., Beekly D., Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology. 46:1996;1592-1596.
26. Esiri M.M., Wilcock G.K. Cerebral amyloid angiopathy in dementia and old age. J. Neurol, Neurosurg. Psychiat. 49:1986;1221-1226.
27. Frackowiak J., Mazur-Kolecka B., Wisniewski H.M., Potempska A., Carroll R.T., Emmerling M.R., Kim K.S. Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res. 676:1995;225-230.
28. Fraser P.E., Nguyen J.T., Inouye H., Surewicz W.K., Selkoe D.J., Podlisny M., Kirschner D.A. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein. Biochemistry. 31:1992;10716-10723.
29. Frautschy S.A., Yang F., Calderón L., Cole G.M. Rodent models of Alzheimer's disease: rat Aβ infusion approaches to amyloid deposits. Neurobiol. Aging. 17:1996;311-321.
30. Friedland R.P., Reno J.M., Majocha R.E., VanHaight C., Lyle L.R., Berridge M.S., Miraldi F., Marotta C.A. Immunochemistry of Alzheimer's disease: development of a monoclonal antibody targeting the amyloid β protein for neuroimaging. J. Cereb. Blood Flow Metab. 13:1993;S244.
31. Fukuchi K., Ho L., Younkin S.G., Kunkel D.D., Ogburn C.E., Deeb S.S., Nochlin D., Wegiel J., Wisniewski H.M., Martin G.M. High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice. Am. J. Path. 149:1996;219-227.
32. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagoplan S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
33. Gearing M., Mori H., Mirra S.S. Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann. Neurol. 39:1996;393-399.
34. Gearing M., Rebeck G.W., Hyman B.T., Tigges J., Mirra S.S. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;9382-9386.
35. 40 is a major form of β-amyloid in non-human primates, Neurobiol. Aging, (in press).
36. Ghersi-Egea J.-F., Gorevic P.D., Ghiso J., Frangione B., Patlak C.S., Fenstermacher J.D. Fate of cerebrospinal fluid-borne amyloid β-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J. Neurochem. 67:1996;880-883.
37. 1-40 labels amyloid deposits in the aged primate brain in vivo, Neuroreport 7 (1996) 2607-2611.
38. Ghiso J., Jensson O., Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of γ-trace basic protein (cystatin C). Proc. Natl. Acad. Sci. 83:1986;2974-2978.
39. Giaccone G., Verga L., Finazzi M., Pollo B., Tagliavini F., Frangione B., Bugiani O. Cerebral preamyloid deposits and congophilic angiopathy in aged dogs. Neurosci. Lett. 114:1990;178-183.
40. Glenner G.G. Amyloid deposits and amyloidosis. The β-fibrilloses. (First of two parts). N. Engl. J. Med. 302:1980;1283-1333.
41. Gomez-Isla T., West H.L., Rebeck G.W., Hart S.D., Growdon J.H., Locascio J.J., Perls T.T., Lipsitt L.A., Hyman B.T. Clinical and pathological correlates of apolipoprotein Eε 4 in Alzheimer's disease. Ann. Neurol. 39:1996;62-70.
42. Gowing E., Roher A.E., Woods A.S., Cotter R.J., Chaney M., Little S.P., Ball M.J. Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 269:1994;10987-10990.
43. Graffagnino C., Herbstreith M.H., Schmechel D.E., Levy E., Roses A.D., Alberts M.J. Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage. Stroke. 26:1995;2190-2193.
44. Greenberg B.D., Savage M.J., Howland D.S., Ali S.M., Siedlak S.L., Perry G., Siman R., Scott R.W. APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology. Neurobiol. Aging. 17:1996;153-172.
45. Greenberg S.M., Rebeck G.W., Vonsattel J.-P.G., Gomez-Isla T., Hyman B.T. Apolipoprotein Eε 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38:1995;254-259.
46. Haan J., Hardy J.A., Roos R.A.C. Hereditary cerebral hemorrhage with amyloidosis - Dutch type: its importance for Alzheimer research. Trends Neurosci. 14:1991;231-234.
47. Haan J., Lanser J.B.K., Zijderveld I., van der Does I.G.F., Roos R.A.C. Dementia in hereditary cerebral hemorrhage with amyloidosis - Dutch type. Arch. Neurol. 47:1990.
48. Haan J., Roos R.A.C., Briët P.E., Herpers M.J.H.M., Luyendijk W., Bots G.T.A.M. Hereditary cerebral hemorrhage with amyloidosis-Dutch type: clinical characteristics. Clin. Neurol. Neurosurg. 91:1989;285-290.
49. Haass C., Selkoe D.J. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell. 75:1993;1039-1042.
50. Hendriks L., van Duijn C.M., Cras P., Cruts M., Van Hul W., van Harskamp F., Warren A., McInnis M.G., Antonarakis S.E., Martin J.-J., Hofman A., Van Broeckhoven C. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nature Gen. 1:1992;218-221.
51. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
52. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., Rohan de Silva H.A., Kittel A., Saitoh T. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 14:1995;467-475.
53. Joachim C.L., Duffy L.K., Morris J.H., Selkoe D.J. Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res. 474:1988;100-111.
54. Johnstone E.M., Chaney M.O., Norris F.H., Pascual R., Little S.P. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Mol. Brain Res. 10:1991;299-305.
55. Kalaria R.N., Grahovac I. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res. 516:1990;349-353.
56. C.S. Kase, Cerebral Amyloid Angiopathy, in: C.S. Kase, L.R. Caplan (Eds.), Intracerebral Hemorrhage, Butterworth-Heinemann, Boston, 1994, pp. 179-200.
57. Kawai M., Cras P., Siedlak S., Lowery D., Gonzales-DeWhitt P., Greenberg B., Shelton E., Gambetti P., Perry G. Role of vascular smooth muscle cells in amyloid deposition in cerebral amyloid angiopathy. J. Neuropath. Exp. Neurol. 49:1990;331.
58. Kawai M., Kalaria R.N., Cras P., Siedlak S.L., Velasco M.E., Shelton E.R., Chan H.W., Greenberg B.D., Perry G. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res. 623:1993;142-146.
59. Kisilevsky R., Axelrad M., Corbett W., Brunet S., Scott F. The role of inflammatory cells in the pathogenesis of amyloidosis. Lab. Invest. 37:1977;544-553.
60. Kowall N.W., McKee A.C., Yankner B.A., Beal M.F. In vivo neurotoxicity of beta-amyloid [β(1-40)] and the β(25-35) fragment. Neurobiol. Aging. 13:1992;537-542.
61. Kurz A., Lautenschlager N., Haupt M., Zimmer R., von Thülen B., Altland K., Lauter H., Müller U. Das Apolipoprotein E-ε4-Allel ist ein Risikofaktor für die Alzheimer Krankheit mit frühem und spätem Beginn. Nervenarzt. 65:1994;774-779.
62. LaFerla F.M., Tinkle B.T., Bieberich C.J., Haudenschild C.C., Jay G. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Gen. 9:1995;21-30.
63. Levy E., Amorim A., Frangione B., Walker L.C. β-amyloid precursor protein gene in squirrel monkeys with cerebral amyloid angiopathy. Neurobiol. Aging. 16:1995;805-808.
64. Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberburg I., van Duinen S.G., Bots G.T.A.M., Luyendijk W., Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 248:1990;1124-1126.
65. Levy E., Lopez-Otin C., Ghiso J., Geltner D., Frangione B. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J. Exp. Med. 169:1989;1771-1778.
66. Löfberg H., Grubb A.O., Nilsson E.K., Jensson O., Budmundsson G., Blöndal H., Arnason A., Thorsteinsson L. Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal fluid proteins in hereditary cerebral hemorrhage with amyloidosis. Stroke. 18:1987;431-440.
67. Luyendijk W., Vegter-van der Vlis M., Went L.N. Epidemiological and clinical aspects of hereditary cerebral hemorrhage in Dutch families. Acta Neurol. Scand. 73:1986;313.
68. Majocha R.E., Reno J.M., Friedland R.P., VanHaight C., Lyle L.R., Marotta C.A. Development of a monoclonal antibody specific for β/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy. J. Nucl. Med. 33:1992;2184-2189.
69. Mandybur T.I. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology. 25:1975;120-126.
70. Maness L.M., Banks W.A., Podlisny M.B., Selkoe D.J., Kastin A.J. Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci. 55:1994;1643-1650.
71. Maruyama K., Ikeda S.I.T., Allsop D., Yanagisawa N. Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to β protein and cystatin C. Stroke. 21:1990;397-403.
72. McGeer P.L., Rogers J., McGeer E.G. Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer Dis. Assoc. Disorders. 8:1994;149-158.
73. Mesulam M., Carson K., Price B., Geula C. Cholinesterases in the amyloid angiopathy of Alzheimer's disease. Ann. Neurol. 31:1992;565-569.
74. Miyakawa T., Sumiyoshi S., Murayama E., Deshimaru M. Ultrastructure of capillary plaque-like degeneration in senile dementia. Acta Neuropathol. 29:1974;229-236.
75. Morelli L., Wei L., Amorim A., McDermid J., Abee C.R., Frangione B., Walker L.C., Levy E. Cerebrovascular amyloidosis in squirrel monkeys and rhesus monkeys: apolipoprotein E genotype. FEBS Lett. 379:1996;132-134.
76. Mufson E.J., Benzing W.C., Cole G.M., Wang H., Emerich D.F., Sladek J.R., Morrison J.H., Kordower J.H. Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: colocalization with amyloid plaques. Neurobiol. Aging. 15:1994;621-627.
77. Nagy Z., Esiri M.M., Jobst K.A., Johnston C., Litchfield S., Sim E., Smith A.D. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience. 69:1995;757-761.
78. Nakamura S., Nakayama H., Uetsuka K., Sasaki N., Uchida K., Goto N. Senile plaques in an aged two-humped (Bactrian) camel (Camelus bactrianus). Acta Neuropathol. 90:1995;415-418.
79. Nakamura S., Tamaoka A., Sawamura N., Shoji S., Nakayama H., Ono F., Sakakibara I., Yoshikawa Y., Mori H., Goto N., Doi K. Carboxyl end-specific monoclonal antibodies to amyloid β protein (Aβ) subtypes (Aβ42-43) differentiate Aβ in senile plaques and amyloid angiopathy in brains of aged cynomolgus monkeys. Neurosci. Lett. 201:1995;151-154.
80. Näslund J., Thyberg J., Tjernberg L.O., Wernstedt C.A.R.K., Bogdanovic N., Gandy S.E., Lannfelt L., Terenius L., Nordstedt C. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron. 15:1995;219-228.
81. Ohm T.G., Kirca M., Bohl J., Scharnagl H., Groß W., März W. Apolipoprotein E polymorphism influences not only cerebral plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience. 66:1995;583-587.
82. Ólafsson Í., Thorsteinsson L., Jensson Ó. The molecular pathology of hereditary cystatin C amyloid angiopathy causing brain hemorrhage. Brain Path. 6:1996;121-126.
83. Pardridge W.M. New approaches to drug delivery through the blood-brain barrier. Trends Biotech. 12:1994;239-245.
84. Pauli B., Luginbühl H. Fluorescenzmikroskopische Untersuchungen der cerebralen Amyloidose bei alten Hunden und senilen Menschen. Acta Neuropath. 19:1971;121-128.
85. Perlmutter L.S., Chui H.C. Microangiopathy, the vascular basement membrane and Alzheimer's disease - a review. Brain Res. Bull. 24:1990;677-686.
86. Petersen R.B., Tresser N.J., Richardson S.L., Gali M., Goren H., Gambetti P. A family with oculoleptomeningeal amyloidosis and dementia has a mutation in the transthyretin gene. J. Neuropath. Exp. Neurol. 54:1995;8.
87. Pirttila T., Mehta P.D., Soininen H., Kim K.S., Heinonen O., Paljãrvi L., Kosunen O., Riekkinin P., Wisniewski H.M. Cerebrospinal fluid concentrations of soluble amyloid β-protein and apolipoprotein E in patients with Alzheimer's disease. Arch. Neurol. 53:1996;189-193.
88. Podlisny M.B., Stephenson D.T., Frosch M.P., Lieberburg I., Clemens J.A., Selkoe D.J. Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol. Aging. 13:1992;561-567.
89. Podlisny M.B., Tolan D.R., Selkoe D.J. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am. J. Path. 138:1991;1423-1435.
90. Poduri A., Gearing M., Rebeck G.W., Mirra S.S., Tigges J., Hyman B.T. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Am. J. Path. 144:1994;1183-1187.
91. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinistö L., Halonen P., Kontula K. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N. Engl. J. Med. 333:1995;1242-1247.
92. Prelli F., Castaño E., Glenner G.G., Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51:1988;648-651.
93. Prelli F., Castaño E.M., van Duinen S.G., Bots G.T.A.M., Luyendijk W., Frangione B. Different processing of Alzheimer's β-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Biochem. Biophys. Res. Commun. 151:1988;1150-1155.
94. Premkumar D.R.D., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Path. 148:1996;2083-2095.
95. Prior R., D'Urso D., Frank R., Prikulis I., Pavlakovic G. Loss of vessel wall viability in cerebral amyloid angiopathy. Neuroreport. 7:1996;562-564.
96. Prior R., D'Urso D., Frank R., Prikulis I., Pavlakovic G. Experimental deposition of Alzheimer amyloid β-protein in canine leptomeningeal vessels. Neuroreport. 6:1995;1747-1751.
97. S.B. Prusiner, The prion diseases, Sci. Am., January (1995) 48-57.
98. Quon D., Wang Y., Catalano R., Scardina J.M., Murakami K., Cordell B. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature. 352:1991;239-241.
99. Roertgen K.E., Parisi J.E., Clark H.B., Barnes D.L., O'Brien T.D., Johnson K.H. Aβ-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo). Neurobiol. Aging. 17:1996;243-248.
100. Roher A.E., Lowenson J.D., Clarke S., Woods A.S., Cotter R.J., Gowing E., Ball M.J. β-Amyloid (1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;10836-10840.
101. 1-40/vector complex. Proc. Natl. Acad. Sci. USA. 92:1995;10227-10231.
102. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Jon S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
103. Schenk D.B., Rydel R.E., May P., Little S., Panetta J., Lieberburg I., Sinha S. Therapeutic approaches related to amyloid-β peptide and Alzheimer's disease. J. Med. Chem. 38:1995;4141-4154.
104. Selkoe D.J. Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease. Neurobiol. Aging. 10:1989;387-395.
105. Selkoe D.J., Bell D.S., Podlisny M.B., Price D.L., Cork L.C. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science. 235:1987;183-187.
106. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormach R., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-327.
107. Shimode K., Fujihara S., Nakamura M., Kobayashi S., Tsunematsu T. Diagnosis of cerebral amyloid angiopathy by enzyme-linked immunosorbent assay of cystatin C in cerebrospinal fluid. Stroke. 22:1991;86-866.
108. Shirahama T., Cohen A.S. Intralysosomal formation of amyloid fibrils. Am. J. Pathol. 81:1975;101-116.
109. Shirahama U., Miura K., Ju S.-T., Kisilevsky R., Gruys E., Cohen A.S. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab. Invest. 62:1990;61-68.
110. Smetana H. Experimental study of amyloid formation. Bull. Johns Hopkins Hospital. 37:1925;383-391.
111. Smetana H. The relation of the reticulo-entdothelial system to the formation of amyloid. J. Exp. Med. 45:1927;619-632.
112. Snow A.D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T.N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133:1988;456-463.
113. Snow A.D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W.A., Morgan D.G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta amyloid in rat brain. Neuron. 12:1994;219-234.
114. Sommer B., Abramowski D., Bürki K., Dixon K., Duke M., Kelly P., Ledermann B., Paganetti P., Probst A., Sturchler-Pierrat C., Widerhold K.-H., Staufenbiel M. Animal models for Alzheimer's disease based on genetics and pathology. Soc. Neurosci. Abstr. 22:1996;25.
115. Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92:1995;4725-4727.
116. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
117. Subcommittee of WHO-IUIS Nomenclature, Bull. World Health Org., 71 (1993) 105-108.
118. Tagliavini F., Ghiso J., Timmers W.F., Giaccone G., Bugiani O., Frangione B. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab. Invest. 62:1990;761-767.
119. Tekirian T.L., Cole G.M., Russell M.J., Yang F., Wekstein D.R., Patel E., Snowdon D.A., Markesbery W.R., Geddes J.W. Carboxy terminal of β-amyloid deposits in aged human, canine, and polar bear brains. Neurobiol. Aging. 17:1996;243-248.
120. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;111-168.
121. Tigges J., Gordon T.P., McClure H.M., Hall E.C., Peters A. Survival rate and life span of rhesus monkeys at the Yerkes Regional Primate Research Center. Am. J. Primatol. 15:1988;263-273.
122. Timmers W.F., Tagliavini F., Haan J., Frangione B. Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis - Dutch type. Neurosci. Lett. 118:1990;223-226.
123. Tomonaga M. Cerebral amyloid angiopathy in the elderly. J. Am. Geriat. Soc. XXIX:1981;151-157.
124. Uchida K., Miyauchi Y., Nakayama H., Goto N. Amyloid angiopathy with cerebral hemorrhage and senile plaque in aged dogs. Jpn. J. Vet. Sci. 52:1990;605-611.
125. Uchida K., Nakayama H., Goto N. Pathological studies on cerebral amyloid angiopathy, senile plaques and amyloid deposition in visceral organs in aged dogs. J. Vet. Med. Sci. 53:1991;1037-1042.
126. Uno H., Alsum P.B., Dong S., Richardson R., Zimbric M.L., Thieme C.S., Houser W.D. Cerebral amyloid angiopathy and plaques, and visceral amyloidosis in aged macaques. Neurobiol. Aging. 17:1996;275-282.
127. Uno H., Walker L.C. The age of biosenescence and the incidence of cerebral β-amyloidosis in aged captive rhesus monkeys. Ann. N.Y. Acad. Sci. 695:1993;232-235.
128. Van Broeckhoven C., Haan J., Bakker E., Hardy J.A., Van Hul W., Wehnert A., Vegter-Van der Vlis M., Roos R.A.C. Amyloid β-protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science. 248:1990;1120-1122.
129. Van Duinen S.G., Castaño E.M., Prelli F., Bots G.T.A.B., Luyendijk W., Frangione B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 84:1987;5991-5994.
130. Van Duinen S.G., Maat-Schieman M.L.C., Bruijn J.A., Haan J., Roos R.A.C. Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits. Lab. Invest. 73:1995;183-189.
131. Vidal R., Garzuly F., Budka H., Lalowski M., Linke R.P., Brittig F., Frangione B., Wisniewski T. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G). Am. J. Path. 148:1996;361-366.
132. Vinters H.V. Cerebral amyloid angiopathy: a critical review. Stroke. 18:1987;311-324.
133. H.V. Vinters, Cerebral amyloid angiopathy, in: H.J.M. Barnett, J.P. Mohr, B.M. Stein, F.M. Yatsu, Stroke: Pathophysiology, Diagnosis and Management, Churchill Livingstone, New York, 1992, pp. 821-858.
134. Vinters H.V., Gilbert J.J. Incidence and complications in the aging brain. II. The distribution of amyloid vascular changes Stroke. 14:1983;924-928.
135. Vinters H.V., Nishimura G.S., Lenard Secor D., Pardridge W.M. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am. J. Pathol. 137:1990;233-240.
136. Vinters H.V., Wang Z.Z., Lenard Secor D. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Path. 6:1996;179-195.
137. Walker L.C. Comparative neuropathology of aged non-human primates. Neurobiol. Aging. 14:1993;667.
138. L.C. Walker, Aged non-human primates as models of β-amyloidoses, in: E. Giacobini, R. Becker (Eds.), Alzheimer Disease: Therapeutic Strategies, Birkhäuser, Boston, 1994, pp. 390-394.
139. Walker L.C. The senescent primate brain. Sem. Neurosci. 6:1994;379-385.
140. Walker L.C., Ghilardi J., Rogers S., Catton M., Maggio J.E., Mantyh P.W. In vivo binding of synthetic β-amyloid (Aβ) to endogenous Aβ in aged monkeys. Soc. Neurosci. Abstr. 21:1995;257.
141. Walker L.C., Kitt C.A., Cork L.C., Struble R.G., Dellovade T.L., Price D.L. Multiple transmitter systems contribute neurites to individual senile plaques. J. Neuropathol. Exp. Neurol. 47:1988;138-144.
142. Walker L.C., Kitt C.A., Struble R.E., Wagster M.V., Price D.L., Cork L.C. The neural basis of memory decline in aged monkeys. Neurobiol. Aging. 9:1988;657-666.
143. Walker L.C., Masters C., Beyreuther K., Price D.L. Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol. 80:1990;381-387.
144. Walker L.C., Price D.L., Voytko M.L., Schenk D.B. Labeling of cerebral amyloid in vivo with a monoclonal antibody. J. Neuropathol. Exp. Neurol. 53:1994;377-383.
145. L.C. Walker, R. Warzok, S. Dünnewald, G. Apel, A. Schwarz, R. Egensperger, D. Schreiber, J.C. Troncoso, C. Kessler, Apolipoprotein E ε4 promotes early β-amyloid deposition in the non-demented elderly, Soc. Neurosci. Abstr., 1996, p. 1696.
146. Walker M.L. Menopause in female rhesus monkeys. Am. J. Primatol. 35:1995;59-71.
147. R.W. Warzok, C. Kessler, G. Apel, A. Schwarz, R. Egensperger, D. Schreiber, E.W. Herbst, E. Wolf, R. Walther, L.C. Walker, Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly, Alz. Dis. Assoc. Disorders, in press.
148. Wattendorff A.R., Frangione B., Luyendijk W., Bots G.T.A.M. Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J. Neurol. Neurosurg. Psychiat. 58:1995;699-705.
149. Wegiel J., Wisniewski H.M., Dziewiatkowski J., Tarnawski M., Nowakowski J., Dziewiatkowska A., Soltysiak Z. The origin of amyloid in cerebral vessels of aged dogs. Brain Res. 705:1995;225-234.
150. Wei L., Walker L.C., Levy E. Cystatin C: Icelandic-like mutation in an animal model of cerebrovascular β-amyloidosis. Stroke. 27:1996;2080-2085.
151. Weisgraber K.H., Pitas R.E., Mahley R.W. Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E. Curr. Opinion Struc. Biol. 4:1994;507-515.
152. Wisniewski H., Frackowiak J., Mazur-Kolecka B. In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci. Lett. 183:1995;1-4.
153. Wisniewski H., Johnson A.B., Raine C.S., Kay W.J., Terry R.D. Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. Lab. Invest. 23:1970;287-296.
154. Wisniewski H.M., Bruce M.E., Fraser H. Infectious etiology of neuritic (senile) plaques in mice. Science. 190:1975;1108-1110.
155. Wisniewski H.M., Fraçkowiak J., Zóltowska A., Kim K.S. Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Int. J. Clin. Exp. Invest. 1:1994;8-16.
156. Wisniewski H.M., Moretz R.C., Lossinsky A.S. Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent. Ann. Neurol. 10:1981;517-522.
157. Wisniewski H.M., Wiegel J. β-Amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol. 87:1994;233-241.
158. Wisniewski T., Ghiso J., Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179:1991;1247-1254.
159. Wisniewski T., Lalowski M., Bobik M., Russell M., Strosznajders J., Frangione B. Amyloid β 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. Biochem. J. 313:1996;575-580.
160. Wong C.W., Quaranta V., Glenner G.G. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc. Natl. Acad. Sci. USA. 82:1985;8729-8732.
161. Yamada M., Itoh Y., Shintaku M., Kawamura J., Jensson Ó., Thornsteinsson L., Suematsu N., Matsushita M., Otomo E. Immune reactions associated with cerebral amyloid angiopathy. Stroke. 27:1996;1155-1162.
162. Yamada M., Tsukagoshi H., Otomo E., Hayakawa M. Cerebral amyloid angiopathy in the aged. J. Neurol. 234:1987;371-376.
163. Yamaguchi H., Ishiguro K., Sugihara S., Nakazato Y., Kawarabayashi T., Sun X., Hirai S. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol. 88:1994;413-419.
164. Yamaguchi H., Yamazaki T., Lemere C.A., Frosch M.P., Selkoe D.J. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am. J. Pathol. 141:1992;249-259.
165. Zlokovic B.V., Ghiso J., Mackic J.B., McComb J.G., Weiss M.H., Frangione B. Blood-brain barrier transport of circulating Alzheimer's amyloid β Biochem. Biophys. Res. Commun. 197:1993;1034-1040.
166. Zlokovic B.V., Martel C.L., Matsubara E., McComb J.G., Zheng G., McCluskey R.T., Frangione B., Ghiso J. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with